SEC Form D · filed May 20, 2019
Finch Therapeutics Group, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (30)
Carter G. Mcnabb · Louisville, CODirectorAlan A. Gross · Somerville, MADirectorJames Burgess · Somerville, MAExecChris Lange · Somerville, MADirectorMatthew N. Whitehead · Hong Kong, Hong KongExec · DirectorBryan Y. Colwell · New York, NYDirectorMichael Galgon · Seattle, WADirectorAlexander T. Edwards · Boston, MAExecZain Kassam · Somerville, MAExecR. J. Price · Somerville, MADirectorAndrew Mulderry · Somerville, MADirectorKerry Song · San Clemente, CAExecJackie N. Charlesworth · Hong Kong, Hong KongDirectorPatrick Dunn · PROVIDENCE, RIExecReiji Morooka · Tokyo, M0DirectorMarc N. Puglia · PROVIDENCE, RIExecJeffery A. Smisek · Somervlle, MADirectorAllison Harr · Seattle, WADirectorBracken T. Darrell · Boston, MAExec · DirectorAndrew Noh · Somerville, MAExecBenjamin Enerson · Somerville, MAExecMark Smith · Somerville, MAExec · DirectorHarry W. Lengsfield · NEW YORK, NYExecMilton Berlinski · New York, NYDirectorTao R. Wang · Newtown Square, PADirectorTodd Haskins · New York, NYExecPeter Aberg · New York, NYDirectorDavid T. Sinclair · Boston, MAExecTimothy H. Baynes · Strafford, MODirectorLair G. Kennedy · Louisville, COExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗